🇺🇸 FDA
Patent

US 8324165

Compositions for treating arthritis comprising HG1023575 polypeptide

granted A61PA61P19/02

Quick answer

US patent 8324165 (Compositions for treating arthritis comprising HG1023575 polypeptide) held by Five Prime Therapeutics, Inc. expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Five Prime Therapeutics, Inc.
Grant date
Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P19/02